Plavix Settlement Updated To Appease FTC
The companies agreed to move the date for a generic version up three months. Canadian drug maker Apotex can sell its generic version starting on June 1, 2011 instead of on Sept. 17, 2011, according to Bristol-Myers, the U.S. partner of French pharmaceutical giant Sanofi-Aventis, and Apotex....
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login